• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
US FDA Drug Approval Strategies for Pharmaceutical Industry
US FDA Drug Approval Strategies for Pharmaceutical Industry

... submission to the Food and Drug Administration (FDA) that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs. ...
I The Rise of The empoweRed ConsumeR
I The Rise of The empoweRed ConsumeR

... Nutrient content descriptors were rare; indeed, the FDA prohibited any reference whatsoever to cholesterol. Claims regarding foods’ usefulness in preventing disease were also virtually absent from labels; the FDA considered any such statement to render the product an unapproved—and thus illegal—drug ...
Principles of Pharmacology
Principles of Pharmacology

...  Drug is similar to drugs already on the market (Ssimilar) Other classifications  Drugs indicated for AIDS or HIV-related disease  Drugs developed to treat life-threatening or severely debilitating illness  Orphan drugs ...
How Drugs are Handled in the Body PDF
How Drugs are Handled in the Body PDF

... Unfortunately this risk is not lessened by the so-called “shorter” acting benzodiazpines like Flurazepam which, whilst possessing a shorter half life, are quickly metabolised into longer-acting The kidneys' ability to excrete drugs also depends on urine flow, end-products with half lives of several ...
APPLICATIONS FOR INVESTIGATIONAL NEW DRUGS (INDs
APPLICATIONS FOR INVESTIGATIONAL NEW DRUGS (INDs

... causing photosensitivity or the nature of action suggests such a potential) 12.5.6 Rectal tolerance test (For all preparations meant for rectal administration) 12.6 Genotoxicity 12.7 Allergenicity/Hypersensitivity ...
Research Notes - California Workers` Compensation Institute
Research Notes - California Workers` Compensation Institute

... As the utilization of co-packs surged in early 2007, the percentage of billed dollars for these prescriptions rose sharply, and that percentage remained high through the end of that year before moderating in 2008. Meanwhile, bulk drugs also were becoming more prevalent in workers’ compensation, so t ...
Hydrocodone - Heads Up
Hydrocodone - Heads Up

... accumbens (a key structure in reward, motivation, and addiction), resulting in initial euphoria. The high levels of Vicodin® abuse may be linked to its widespread availability—a fact that becomes even more troubling when considering the health risks of abusing hydrocodone and other prescription drug ...
Sleeping Drugs
Sleeping Drugs

... who feel anxious, tense and/or miserable. In such patients insomnia may be only one of a group of mental and/or physical symptoms which they may experience. Therefore, it is inappropriate to take sleeping drugs as the only form of treatment. Some drugs can cause insomnia. For example, caffeine in te ...
From Morphine to Methadone: Maintenance Drugs in The Treatment
From Morphine to Methadone: Maintenance Drugs in The Treatment

... what are clearly powerful biological phenomena. grounded in scientific researchin both pharmacology and brain functioning. However that is not the whole story and our biological understanding of addiction (as a disorder of neurotransmission), does not mean that the social and psychological issuesin ...
Systemic meds and ocular side effects revised
Systemic meds and ocular side effects revised

... Patients at greatest risk are those on hydroxychloroquine for longer than 5 years and those with renal or liver Elderly, thin patients may also be overdosed, as may obese patients. Dosing regimens are based on body weight, but hydroxychloroquine is primarily absorbed by cellular tissue. Since adipos ...
Slide 1
Slide 1

... determine, and difficult to convince the regulatory agency . Ω There is little predictability for BCS classification drugs beyond Class 1 primarily due to the difficulty of determining and proving 90% absorption.  many drugs are misclassified (e.g. HIV protease inhibitors as Class 4 compounds)). ...
Drugs of Abuse: Psychedelic Agents
Drugs of Abuse: Psychedelic Agents

... practices involving the use of psychedelic drugs. The use of the term psychedelic emphasizes the ability of psychedelic drugs to facilitate exploration of the psyche, which is fundamental to most methods of psychedelic psychotherapy. Many studies found that the use of psychedelic drug greatly facili ...
Department of Pharmacology
Department of Pharmacology

... 5. Completion of the whole course of pharmacology (Final Grade): The mean grade of all the Component Tests a student wrote (or the grade from the Integrative Test, if passed), together with the result of the Final Exam, shall be the basis for calculation the Final Grade from the pharmacology course, ...
Principles of Pediatrics Pharmacotherapy
Principles of Pediatrics Pharmacotherapy

... body weight or surface area of a pediatric patient extrapolated from adult data. BA, PK, PD, efficacy, and adverse-effect information can differ markedly between pediatric and adult patients, as well as among pediatric patients,  because of differences in age, organ function, and disease state. ...
Document
Document

... The following are the aspects of comparison between the topical and the systemic drugs 1. Concentrations at the site of infection: topical drugs are more concentrated at the site of infection bcz you are applying the drug directly on the site of the infection 2. Side effects : the systemic drugs hav ...
Hyoscine Butylbromide
Hyoscine Butylbromide

... Disposition in the Body Poorly absorbed after oral administration. About 90% of an oral dose is eliminated in the faeces and <10% is excreted in the urine. After IV administration, about 40% of a dose is excreted in the urine. Half­life Plasma half­life, about 8 h. Protein Binding About 10%. Dose 2 ...
the WHO Drug Dictionary
the WHO Drug Dictionary

... New drug names are routinely classified and added, but at a small cost it is possible to have drugs entered on request within 3 working days. Drugs are not deleted from the dictionary, although the products may no longer be on the market. Drug information has been entered into this database since 19 ...
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF DILTIAZEM HYDROCHLORIDE
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF DILTIAZEM HYDROCHLORIDE

... permeable) drug with extensive and highly variable hepatic first pass metabolism following oral administration, with systemic bioavailability of between 36-50% and half life of 3.5 ± 1.2 hours. When such a drug administered in conventional immediate release dosage form, the frequency of administrati ...
drugs and the kidney
drugs and the kidney

... drug concentrationtime profile that is ...
Level of Evidence Associated with FDA Safety Communications with
Level of Evidence Associated with FDA Safety Communications with

... The Food and Drug Administration is tasked with protecting the public health from safety risks associated with medications and other products.1 Clinical trial information is extensively reviewed prior to market approval and postmarketing safety reports are used to ensure that harm is not disproporti ...
PHARMACOLOGY
PHARMACOLOGY

... Introduction and application of molecular pharmacological techniques: Elisa, Western Blotting, SDSPage and electrophoresis, flow cytometry. Module 04 5. Monoclonal Antibodies: Scope and limitation of monoclonal antibodies, formation and selection of hybrid cells, identification of specific antibody ...
nhse_qa43_7_final - Specialist Pharmacy Service
nhse_qa43_7_final - Specialist Pharmacy Service

... with as much as 60% of an oral dose undergoing ‘first pass metabolism’, so only about 40% of the dose is bioavailable (1). COCs have a higher failure rate when women are taking concomitant hepatic enzyme-inducing drugs. Antiepileptic drugs (AEDs) such as carbamazepine, eslicarbazepine, oxcarbazepine ...
Anti-tuberculous drugs
Anti-tuberculous drugs

... • Multiple drugs are used to reduce the emergence of resistance • Given as combination tablets • Taken 30 min before the breakfast as absorption of rifampicin is influenced by food ...
System Novel Herbal Drug Delivery (NHDDS): the need of Hour Anju Dhiman
System Novel Herbal Drug Delivery (NHDDS): the need of Hour Anju Dhiman

... their application to cure variety of diseases with less toxic effects and better therapeutic effects. However, some limitations of herbal extracts/ plant actives like instability in highly acidic pH, liver metabolism etc. has led to drug levels below therapeutic concentration in the blood resulting ...
Unit 4 Drug Stability
Unit 4 Drug Stability

... Drug Stability Steps to prevent instability Design of product based on proper pre-formulation studies. ...
< 1 ... 56 57 58 59 60 61 62 63 64 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report